Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Capricor Therapeutics (CAPR) Other Non Operating Income (2021)

Capricor Therapeutics (CAPR) has 4 years of Other Non Operating Income data on record, last reported at $318160.0 in Q2 2021.

  • For Q2 2021, Other Non Operating Income changed N/A year-over-year to $318160.0; the TTM value through Jun 2021 reached $82649.0, changed N/A, while the annual FY2012 figure was $695981.0, 8197.34% up from the prior year.
  • Other Non Operating Income reached $318160.0 in Q2 2021 per CAPR's latest filing, up from $11738.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $318160.0 in Q2 2021 and bottomed at $318160.0 in Q2 2021.